Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

4724 ARTÍCULOS , VIENDO DEL 1501 AL 1515

Lidocaine for chemical cardioversion of orthodromic atrioventricular reciprocating tachycardia in dogs

Wright KN, Nguyenba T, Irvin HM.

J Vet Intern Med. 2019 Jul;33(4):1585-1592. doi: 10.1111/jvim.15546. Epub 2019 Jun 20.

Copper and copper nanoparticles toxicity and their impact on basic functions in the body

Pohanka M.

Bratisl Lek Listy. 2019;120(6):397-409. doi: 10.4149/BLL_2019_065.

LRRK2 Kinase Inhibitors as Possible Therapy for Parkinson's Disease and Other Neurodegenerative Disorders

Abdel-Magid AF.

ACS Med Chem Lett. 2019 May 24;10(6):846-847. doi: 10.1021/acsmedchemlett.9b00216. eCollection 2019 Jun 13.

A Case of Carbon Monoxide-Induced Delayed Neurological Sequelae Successfully Treated with Hyperbaric Oxygen Therapy, N-Acetylcysteine, and Glucocorticoids: Clinical and Neuroimaging Follow-Up

Spina V, Tomaiuolo F, Celli L, Bonfiglio L, Cecchetti L, Carboncini MC.

Case Rep Neurol Med. 2019 May 15;2019:9360542. doi: 10.1155/2019/9360542. eCollection 2019.

The Effect of Magnesium Deficiency on Neurological Disorders: A Narrative Review Article

Xue W, You J, Su Y, Wang Q.

Iran J Public Health. 2019 Mar;48(3):379-387.

Voluntary exercise delays progressive deterioration of markers of metabolism and behavior in a mouse model of Parkinson's disease

Lai JH, Chen KY, Wu JC, Olson L, Brené S, Huang CZ, Chen YH, Kang SJ, Ma KH, Hoffer BJ, Hsieh TH, Chiang YH.

Brain Res. 2019 Oct 1;1720:146301. doi: 10.1016/j.brainres.2019.146301. Epub 2019 Jun 18.

Parkinson's disease and light: The bright and the Dark sides

Maggio R, Vaglini F, Rossi M, Fasciani I, Pietrantoni I, Marampon F, Corsini GU, Scarselli M, Millan MJ.

Brain Res Bull. 2019 Aug;150:290-296. doi: 10.1016/j.brainresbull.2019.06.013. Epub 2019 Jun 19.

Introduction and classical environmental risk factors for Parkinson

Tranchant C.

Rev Neurol (Paris). 2019 Dec;175(10):650-651. doi: 10.1016/j.neurol.2019.04.006. Epub 2019 Jun 18.

Sleep Disturbance as Potential Risk and Progression Factor for Parkinson's Disease

Bohnen NI, Hu MTM.

J Parkinsons Dis. 2019;9(3):603-614. doi: 10.3233/JPD-191627.

The role of Optical Coherence Tomography in Parkinsonism: A critical review

Mailankody P, Lenka A, Pal PK.

J Neurol Sci. 2019 Aug 15;403:67-74. doi: 10.1016/j.jns.2019.06.009. Epub 2019 Jun 12.

Hyperpolarization-Activated Cyclic Nucleotide-Gated Channels: An Emerging Role in Neurodegenerative Diseases

Chang X, Wang J, Jiang H, Shi L, Xie J.

Front Mol Neurosci. 2019 Jun 5;12:141. doi: 10.3389/fnmol.2019.00141. eCollection 2019.

Successful treatment of psychosis in a patient with Kufor-Rakeb syndrome with low dose aripiprazole: a case report

McNeil-Gauthier AL, Brais B, Rouleau G, Anoja N, Ducharme S.

Neurocase. 2019 Jun-Aug;25(3-4):133-137. doi: 10.1080/13554794.2019.1625928. Epub 2019 Jun 24.

Gene-targeting approaches for movement disorders: recent advances

Kaplitt MG.

Curr Opin Neurol. 2019 Aug;32(4):566-570. doi: 10.1097/WCO.0000000000000719.

Interactions between iron and α-synuclein pathology in Parkinson's disease

Chen B, Wen X, Jiang H, Wang J, Song N, Xie J.

Free Radic Biol Med. 2019 Sep;141:253-260. doi: 10.1016/j.freeradbiomed.2019.06.024. Epub 2019 Jun 22.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias